UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058944
Receipt number R000067411
Scientific Title Prospective Multicenter Observational Study on Cardiac and Pulmonary Complications in Locally Advanced Lung Cancer Patients Treated with Carbon-Ion Radiotherapy
Date of disclosure of the study information 2025/09/01
Last modified on 2025/08/31 16:24:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter Observational Study on Cardiac and Pulmonary Complications in Advanced Lung Cancer Patients Treated with Carbon-Ion Radiotherapy

Acronym

Multicenter Study on Complications in Advanced Lung Cancer Patients Treated with CIRT

Scientific Title

Prospective Multicenter Observational Study on Cardiac and Pulmonary Complications in Locally Advanced Lung Cancer Patients Treated with Carbon-Ion Radiotherapy

Scientific Title:Acronym

LA-Lung-AR-JCROS

Region

Japan


Condition

Condition

Locally Advanced Lung Cancer

Classification by specialty

Pneumology Chest surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The objective is to clarify the effects of heavy-ion beam therapy on the heart, lungs, and esophagus in patients with locally advanced lung cancer by prospectively evaluating adverse events related to these organs in a multicenter study.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Adverse reaction occurring in the heart, lungs, and esophagus within 24 months after Carbon ion Radiotherapy

Key secondary outcomes

Overall survival period, local control period, and progression free survival period


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who received carbon ion radiotherapy for locally advanced lung cancer between September 1, 2025, and March 31, 2028

Key exclusion criteria

If the research subject or their representative refuses the use of their data for this research

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hitoshi
Middle name
Last name Isihkawa

Organization

QST Hospital, National Institute for Quantum and Radiological Sciences and Technology

Division name

Department of Diagnostic Radiology and Radiation Oncology

Zip code

2638555

Address

4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba, Japan

TEL

0432063306

Email

Ishikawa.hitoshi@qst.go.jp


Public contact

Name of contact person

1st name Mio
Middle name
Last name Nakajima

Organization

QST Hospital, National Institute for Quantum and Radiological Sciences and Technology

Division name

Department of Diagnostic Radiology and Radiation Oncology

Zip code

2638555

Address

4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba, Japan

TEL

0432063306

Homepage URL


Email

nakajima.mio@qst.go.jp


Sponsor or person

Institute

National Institutes for Quantum Science and Technology

Institute

Department

Personal name

Mio Nakajima


Funding Source

Organization

National Institutes for Quantum Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

QST Hospital, National Institute for Quantum and Radiological Sciences and Technology

Address

4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba, Japan

Tel

0432063306

Email

helsinki@qst.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 07 Month 22 Day

Date of IRB

2025 Year 08 Month 27 Day

Anticipated trial start date

2025 Year 09 Month 01 Day

Last follow-up date

2030 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The objective of this study is to evaluate adverse reactions to heart, lung, and esophagus in Carbon ion radiotherapy (CIRT) for locally advanced lung cancer through a multicenter, prospective assessment, thereby clarifying the effects of CIRT on the heart, lungs, and esophagus in locally advanced lung cancer. CIRT in Japan is conducted by the Japanese Consortium for Carbon Ion Radiation Therapy (J-CROS). As part of its activities under the National Registration and Clinical Evaluation of CIRT cases, J-CROS has been collecting treatment data (J-CROS data) for all patients who underwent CIRT at domestic facilities into a dedicated database since May 2016. The JCROS data is managed at a data center established within QST Hospital. Applications for its use are accepted based on the rules governing its utilization (J-CROS Data Usage Rules). This study will perform analyses using this J-CROS data.


Management information

Registered date

2025 Year 08 Month 31 Day

Last modified on

2025 Year 08 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067411